Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 900.51 Million CNY | -18.28% |
| 2022 | 1.1 Billion CNY | -19.2% |
| 2021 | 1.36 Billion CNY | 46.53% |
| 2020 | 930.77 Million CNY | 1437.64% |
| 2019 | 60.53 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 783.81 Million CNY | -12.96% |
| 2024 Q2 | 783.81 Million CNY | 0.0% |
| 2023 Q2 | 983.02 Million CNY | 7.88% |
| 2023 FY | 900.51 Million CNY | -18.28% |
| 2023 Q1 | 911.2 Million CNY | -17.31% |
| 2023 Q3 | 817.89 Million CNY | -16.8% |
| 2023 Q4 | 900.51 Million CNY | 10.1% |
| 2022 Q2 | 1.26 Billion HKD | 0.0% |
| 2022 FY | 1.1 Billion CNY | -19.2% |
| 2022 Q4 | 1.1 Billion CNY | 12.27% |
| 2022 Q3 | 981.51 Million CNY | -22.59% |
| 2021 Q4 | 1.36 Billion HKD | 0.0% |
| 2021 FY | 1.36 Billion CNY | 46.53% |
| 2020 FY | 930.77 Million CNY | 1437.64% |
| 2019 FY | 60.53 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -119.641% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 91.994% |